Trial Outcomes & Findings for Biological Response to Brief Psychological Challenge (NCT NCT04078035)

NCT ID: NCT04078035

Last Updated: 2024-03-01

Results Overview

Serum levels of mitochondrial DNA assessed from blood samples

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

72 participants

Primary outcome timeframe

5 minutes before task, and 5, 10, 20, 30, 45, 60, 75, 90 and 120 minutes after the task.

Results posted on

2024-03-01

Participant Flow

Participants were recruited into this study between 7/23/2020 and 12/17/2021. Healthy volunteers were recruited from advertisements places around campus and through "Pitt+Me," a registry of individuals interested in participating in research taking place at the University of Pittsburgh.

Participants were scheduled for a screening telephone call to determine eligibility. Eligible participants were rescreened at 1st study visit and excluded if they did not meet eligibility criteria. We also excluded individuals on whom we could not insert a functioning intravenous catheter at the first study visit.

Participant milestones

Participant milestones
Measure
Socio-evaluative Speech Stress, Then Control
Participants will attend two laboratory sessions. At the first session, participants will complete a socio-evaluative speech task, which is a widely used, highly effective way to investigate stress responses in a laboratory setting. Participants will prepare and deliver a brief, 3-minute speech defending themselves against an alleged transgression (e.g., running a stop sign). The speech will be delivered in front of a video camera, a mirror and an audience (the interviewer and another staff member). Participants will be told that their non-verbal behaviors are being evaluated. At the second session, participants will rest quietly for the same period as the speech task, in the absence of the stressor. Socio-evaluative speech task: 5-minute speech task designed to induce physiological arousal in a laboratory setting. Control, Quiet Rest: 5-minute quiet rest period.
Control, Then Socio-Evaluative Speech Stress
Participants will attend two laboratory sessions. At the first session, participants will rest quietly for 5 minutes. At the second session, participants will complete a socio-evaluative speech task, which is a widely used, highly effective way to investigate stress responses in a laboratory setting. Participants will prepare and deliver a brief, 3-minute speech defending themselves against an alleged transgression (e.g., running a stop sign). The speech will be delivered in front of a video camera, a mirror and an audience (the interviewer and another staff member). Participants will be told that their non-verbal behaviors are being evaluated. Socio-evaluative speech task: 5-minute speech task designed to induce physiological arousal in a laboratory setting. Control, Quiet Rest: 5-minute quiet rest period.
Session1
STARTED
36
36
Session1
COMPLETED
36
36
Session1
NOT COMPLETED
0
0
Session 2
STARTED
36
36
Session 2
COMPLETED
25
27
Session 2
NOT COMPLETED
11
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Socio-evaluative Speech Stress, Then Control
Participants will attend two laboratory sessions. At the first session, participants will complete a socio-evaluative speech task, which is a widely used, highly effective way to investigate stress responses in a laboratory setting. Participants will prepare and deliver a brief, 3-minute speech defending themselves against an alleged transgression (e.g., running a stop sign). The speech will be delivered in front of a video camera, a mirror and an audience (the interviewer and another staff member). Participants will be told that their non-verbal behaviors are being evaluated. At the second session, participants will rest quietly for the same period as the speech task, in the absence of the stressor. Socio-evaluative speech task: 5-minute speech task designed to induce physiological arousal in a laboratory setting. Control, Quiet Rest: 5-minute quiet rest period.
Control, Then Socio-Evaluative Speech Stress
Participants will attend two laboratory sessions. At the first session, participants will rest quietly for 5 minutes. At the second session, participants will complete a socio-evaluative speech task, which is a widely used, highly effective way to investigate stress responses in a laboratory setting. Participants will prepare and deliver a brief, 3-minute speech defending themselves against an alleged transgression (e.g., running a stop sign). The speech will be delivered in front of a video camera, a mirror and an audience (the interviewer and another staff member). Participants will be told that their non-verbal behaviors are being evaluated. Socio-evaluative speech task: 5-minute speech task designed to induce physiological arousal in a laboratory setting. Control, Quiet Rest: 5-minute quiet rest period.
Session 2
Lost to Follow-up
3
1
Session 2
Unable to insert IV - participant elected to withdraw
8
8

Baseline Characteristics

Biological Response to Brief Psychological Challenge

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Socio-evaluative Speech Stress, Then Control
n=36 Participants
Participants will attend two laboratory sessions. At the first session, participants will complete a socio-evaluative speech task, which is a widely used, highly effective way to investigate stress responses in a laboratory setting. Participants will prepare and deliver a brief, 3-minute speech defending themselves against an alleged transgression (e.g., running a stop sign). The speech will be delivered in front of a video camera, a mirror and an audience (the interviewer and another staff member). Participants will be told that their non-verbal behaviors are being evaluated. At the second session, participants will rest quietly for the same period as the speech task, in the absence of the stressor. Socio-evaluative speech task: 5-minute speech task designed to induce physiological arousal in a laboratory setting. Control, Quiet Rest: 5-minute quiet rest period.
Control, Then Socio-Evaluative Speech Stress
n=36 Participants
Participants will attend two laboratory sessions. At the first session, participants will rest quietly for 5 minutes. At the second session, participants will complete a socio-evaluative speech task, which is a widely used, highly effective way to investigate stress responses in a laboratory setting. Participants will prepare and deliver a brief, 3-minute speech defending themselves against an alleged transgression (e.g., running a stop sign). The speech will be delivered in front of a video camera, a mirror and an audience (the interviewer and another staff member). Participants will be told that their non-verbal behaviors are being evaluated. Socio-evaluative speech task: 5-minute speech task designed to induce physiological arousal in a laboratory setting. Control, Quiet Rest: 5-minute quiet rest period.
Total
n=72 Participants
Total of all reporting groups
Age, Continuous
32 Years
STANDARD_DEVIATION 9 • n=5 Participants
31 Years
STANDARD_DEVIATION 8 • n=7 Participants
31 Years
STANDARD_DEVIATION 9 • n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
19 Participants
n=7 Participants
34 Participants
n=5 Participants
Sex: Female, Male
Male
21 Participants
n=5 Participants
17 Participants
n=7 Participants
38 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
7 Participants
n=5 Participants
4 Participants
n=7 Participants
11 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
White
25 Participants
n=5 Participants
27 Participants
n=7 Participants
52 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
36 participants
n=5 Participants
36 participants
n=7 Participants
72 participants
n=5 Participants
Body Mass Index
24.30 kg/M^2
STANDARD_DEVIATION 4.27 • n=5 Participants
22.61 kg/M^2
STANDARD_DEVIATION 2.68 • n=7 Participants
23.46 kg/M^2
STANDARD_DEVIATION 3.64 • n=5 Participants
Systolic Blood Pressure
113.05 mmHg
STANDARD_DEVIATION 7.82 • n=5 Participants
108.06 mmHg
STANDARD_DEVIATION 10.53 • n=7 Participants
110.78 mmHg
STANDARD_DEVIATION 9.42 • n=5 Participants
Diastolic Blood Pressure
68.92 mmHg
STANDARD_DEVIATION 6.58 • n=5 Participants
65.85 mmHg
STANDARD_DEVIATION 6.73 • n=7 Participants
67.42 mmHg
STANDARD_DEVIATION 6.75 • n=5 Participants

PRIMARY outcome

Timeframe: 5 minutes before task, and 5, 10, 20, 30, 45, 60, 75, 90 and 120 minutes after the task.

Serum levels of mitochondrial DNA assessed from blood samples

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Cell-free Mitochondrial DNA
5 min pre-task
165.79 Copies per uL
Standard Deviation 143.01
405.56 Copies per uL
Standard Deviation 1218.33
Cell-free Mitochondrial DNA
5 min
175.45 Copies per uL
Standard Deviation 144.03
164.45 Copies per uL
Standard Deviation 133.03
Cell-free Mitochondrial DNA
10 min
414.74 Copies per uL
Standard Deviation 1942.78
296.62 Copies per uL
Standard Deviation 629.78
Cell-free Mitochondrial DNA
20 min
153.37 Copies per uL
Standard Deviation 144.03
213.27 Copies per uL
Standard Deviation 511.28
Cell-free Mitochondrial DNA
30 min
151.50 Copies per uL
Standard Deviation 124.64
163.41 Copies per uL
Standard Deviation 147.62
Cell-free Mitochondrial DNA
45 min
171.53 Copies per uL
Standard Deviation 178.85
172.03 Copies per uL
Standard Deviation 155.38
Cell-free Mitochondrial DNA
60 min
150.76 Copies per uL
Standard Deviation 93.06
215.58 Copies per uL
Standard Deviation 437.87
Cell-free Mitochondrial DNA
75 min
183.87 Copies per uL
Standard Deviation 216.89
255.99 Copies per uL
Standard Deviation 549.68
Cell-free Mitochondrial DNA
90 min
187.20 Copies per uL
Standard Deviation 202.77
223.99 Copies per uL
Standard Deviation 272.97
Cell-free Mitochondrial DNA
120 min
161.19 Copies per uL
Standard Deviation 149.77
232.64 Copies per uL
Standard Deviation 279.89

PRIMARY outcome

Timeframe: 5 minutes before to 5, 10, 20, 30, 45, 60, 75, 90, 120 post-task periods

Plasma levels of interleukin-6

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Interleukin-6
5 mins pre-task
1.52 pg/ml
Standard Deviation 1.29
1.40 pg/ml
Standard Deviation 0.99
Interleukin-6
5 min
1.76 pg/ml
Standard Deviation 1.31
1.58 pg/ml
Standard Deviation 0.94
Interleukin-6
10 min
1.61 pg/ml
Standard Deviation 1.24
1.52 pg/ml
Standard Deviation 0.94
Interleukin-6
20 min
2.05 pg/ml
Standard Deviation 1.49
1.78 pg/ml
Standard Deviation 1.01
Interleukin-6
30 min
2.01 pg/ml
Standard Deviation 1.44
1.85 pg/ml
Standard Deviation 1.29
Interleukin-6
45 min
2.30 pg/ml
Standard Deviation 1.70
2.15 pg/ml
Standard Deviation 1.32
Interleukin-6
60 min
2.50 pg/ml
Standard Deviation 1.76
2.27 pg/ml
Standard Deviation 1.34
Interleukin-6
75 min
3.28 pg/ml
Standard Deviation 3.61
3.06 pg/ml
Standard Deviation 2.84
Interleukin-6
90 min
3.80 pg/ml
Standard Deviation 3.78
2.91 pg/ml
Standard Deviation 1.97
Interleukin-6
120 min
4.50 pg/ml
Standard Deviation 3.92
4.72 pg/ml
Standard Deviation 5.31

PRIMARY outcome

Timeframe: 5 minutes before to 5, 10, 20, 30, 45, 60, 75, 90, 120 post-task periods

Plasma levels of tumor necrosis factor-alpha

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Tumor Necrosis Factor-alpha
5 min pre-task
5.92 pg/ml
Standard Deviation 2.21
6.10 pg/ml
Standard Deviation 2.21
Tumor Necrosis Factor-alpha
5 min
6.62 pg/ml
Standard Deviation 1.90
6.81 pg/ml
Standard Deviation 2.79
Tumor Necrosis Factor-alpha
10 min
6.59 pg/ml
Standard Deviation 1.84
6.28 pg/ml
Standard Deviation 1.92
Tumor Necrosis Factor-alpha
20 min
6.70 pg/ml
Standard Deviation 1.72
6.79 pg/ml
Standard Deviation 2.76
Tumor Necrosis Factor-alpha
30 min
6.45 pg/ml
Standard Deviation 1.82
6.35 pg/ml
Standard Deviation 1.89
Tumor Necrosis Factor-alpha
45 min
6.61 pg/ml
Standard Deviation 1.76
6.74 pg/ml
Standard Deviation 2.63
Tumor Necrosis Factor-alpha
60 min
6.41 pg/ml
Standard Deviation 1.65
6.52 pg/ml
Standard Deviation 2.51
Tumor Necrosis Factor-alpha
75 min
6.58 pg/ml
Standard Deviation 1.68
6.79 pg/ml
Standard Deviation 2.64
Tumor Necrosis Factor-alpha
90 min
3.78 pg/ml
Standard Deviation 6.68
6.75 pg/ml
Standard Deviation 1.74
Tumor Necrosis Factor-alpha
120 min
3.92 pg/ml
Standard Deviation 6.43
6.66 pg/ml
Standard Deviation 2.62

SECONDARY outcome

Timeframe: last 5 minutes of baseline, 5-min task-period, first two 5 minutes post-task.

Continuous measurement of heart rate was averaged across 4 periods: last 5 minutes of baseline, 5-min task-period, first two 5 minutes post-task.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Heart Rate
Mean of 5 min pre-task
65.60 Beats per minute
Standard Deviation 9.57
66.76 Beats per minute
Standard Deviation 9.53
Heart Rate
mean of 5 min task period
79.27 Beats per minute
Standard Deviation 14.44
66.36 Beats per minute
Standard Deviation 9.46
Heart Rate
mean of min 1-5 post-task
71.37 Beats per minute
Standard Deviation 10.83
67.43 Beats per minute
Standard Deviation 9.20
Heart Rate
mean of min 6-10 post-task
66.00 Beats per minute
Standard Deviation 9.46
65.03 Beats per minute
Standard Deviation 9.24

SECONDARY outcome

Timeframe: 5 min pre-task and 5, 10, 20, 30, 45, 60, 75, 90, 120

Blood pressure was assessed twice on 10 occasions across the protocol. The two readings on each occasion were averaged.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Systolic Blood Pressure
5 min pre-task
111.18 mmHg
Standard Error 9.47
109.43 mmHg
Standard Error 10.18
Systolic Blood Pressure
5 min post-task
120.29 mmHg
Standard Error 11.71
110.70 mmHg
Standard Error 9.46
Systolic Blood Pressure
10 min post-task
120.02 mmHg
Standard Error 12.58
109.38 mmHg
Standard Error 9.95
Systolic Blood Pressure
20 min post-task
131.55 mmHg
Standard Error 18.09
109.23 mmHg
Standard Error 10.43
Systolic Blood Pressure
30 min post-task
135.63 mmHg
Standard Error 16.62
108.98 mmHg
Standard Error 10.15
Systolic Blood Pressure
45 min post-task
133.42 mmHg
Standard Error 14.32
109.14 mmHg
Standard Error 10.12
Systolic Blood Pressure
60 min post-task
125.43 mmHg
Standard Error 13.54
109.46 mmHg
Standard Error 10.59
Systolic Blood Pressure
75 min post-task
120.61 mmHg
Standard Error 12.45
109.59 mmHg
Standard Error 12.07
Systolic Blood Pressure
90 min post-task
117.15 mmHg
Standard Error 10.58
109.29 mmHg
Standard Error 10.12
Systolic Blood Pressure
120 min post-tsk
115.45 mmHg
Standard Error 12.59
108.32 mmHg
Standard Error 12.25

SECONDARY outcome

Timeframe: 5 min pre-task and 5, 10, 20, 30, 45, 60, 75, 90, 120 post task onset

Diastolic blood pressure was assessed two times on 10 occasions across the protocol. On each occasion, the two measures were averaged.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Diastolic Blood Pressure
5 min pre-task
67.69 mmHg
Standard Deviation 9.47
65.74 mmHg
Standard Deviation 10.18
Diastolic Blood Pressure
5 min post-task onset
72.00 mmHg
Standard Deviation 11.71
66.02 mmHg
Standard Deviation 9.46
Diastolic Blood Pressure
10 min post task onset
72.65 mmHg
Standard Deviation 12.58
65.17 mmHg
Standard Deviation 9.95
Diastolic Blood Pressure
20 min post task onset
79.58 mmHg
Standard Deviation 18.09
65.27 mmHg
Standard Deviation 10.43
Diastolic Blood Pressure
30 min post task onset
81.57 mmHg
Standard Deviation 16.62
66.42 mmHg
Standard Deviation 10.15
Diastolic Blood Pressure
45 min post task onset
79.03 mmHg
Standard Deviation 14.32
65.71 mmHg
Standard Deviation 10.12
Diastolic Blood Pressure
60 min post task onset
71.80 mmHg
Standard Deviation 13.54
66.17 mmHg
Standard Deviation 10.59
Diastolic Blood Pressure
75 min post task onset
68.02 mmHg
Standard Deviation 12.45
65.86 mmHg
Standard Deviation 12.07
Diastolic Blood Pressure
90 min post task onset
66.37 mmHg
Standard Deviation 10.58
64.34 mmHg
Standard Deviation 10.12
Diastolic Blood Pressure
120 min post task onset
66.30 mmHg
Standard Deviation 12.59
64.10 mmHg
Standard Deviation 12.25

SECONDARY outcome

Timeframe: 5 minutes before to 10, 20, 30, 45, 60 minutes post-task periods

Circulating levels of cortisol assessed by ELISA

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Cortisol
5 min pre-task
1.50 ug/dL
Standard Deviation 0.72
1.48 ug/dL
Standard Deviation 0.76
Cortisol
10 min post task onset
1.46 ug/dL
Standard Deviation 0.76
1.30 ug/dL
Standard Deviation 0.62
Cortisol
20 min post task onset
1.57 ug/dL
Standard Deviation 0.86
1.30 ug/dL
Standard Deviation 0.63
Cortisol
30 min post task onset
1.49 ug/dL
Standard Deviation 0.64
1.24 ug/dL
Standard Deviation 0.64
Cortisol
45 min post task onset
1.43 ug/dL
Standard Deviation 0.62
1.24 ug/dL
Standard Deviation 0.66
Cortisol
60 min post task onset
1.35 ug/dL
Standard Deviation 0.72
1.18 ug/dL
Standard Deviation 0.60

SECONDARY outcome

Timeframe: 5 minutes before to 5, 10, 20, 30, & 60 minutes post-task periods

Levels of epinephrine in plasma

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Epinephrine
5 min pre-task
50.56 pg/ml
Standard Deviation 20.09
48.62 pg/ml
Standard Deviation 21.67
Epinephrine
5 min post task onset
54.01 pg/ml
Standard Deviation 23.87
47.46 pg/ml
Standard Deviation 21.19
Epinephrine
10 min post task onset
49.81 pg/ml
Standard Deviation 18.69
52.48 pg/ml
Standard Deviation 28.98
Epinephrine
20 min post task onset
47.95 pg/ml
Standard Deviation 18.12
45.16 pg/ml
Standard Deviation 17.38
Epinephrine
30 min post task onset
47.08 pg/ml
Standard Deviation 16.63
44.26 pg/ml
Standard Deviation 18.35
Epinephrine
60 min post task onset
48.34 pg/ml
Standard Deviation 17.78
41.64 pg/ml
Standard Deviation 16.43

SECONDARY outcome

Timeframe: 5 minutes before to 5, 10, 20, 30, & 60 minutes post-task periods

Levels of norepinephrine in plasma

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Norepinephrine
5 min pre-task
522.86 pg/ml
Standard Deviation 228.82
480.48 pg/ml
Standard Deviation 175.92
Norepinephrine
5 min post-task onset
540.39 pg/ml
Standard Deviation 178.62
485.44 pg/ml
Standard Deviation 157.60
Norepinephrine
10 min post-task
526.93 pg/ml
Standard Deviation 187.47
484.38 pg/ml
Standard Deviation 151.81
Norepinephrine
20 min post-task
494.17 pg/ml
Standard Deviation 173.34
470.70 pg/ml
Standard Deviation 172.50
Norepinephrine
30 min post-task
477.84 pg/ml
Standard Deviation 191.16
476.14 pg/ml
Standard Deviation 155.51
Norepinephrine
60 min post-task
472.74 pg/ml
Standard Deviation 156.83
461.97 pg/ml
Standard Deviation 160.05

SECONDARY outcome

Timeframe: Pre-task, task, and 1-5 and 6-10 minutes post task

Interbeat intervals of heart rate assessed by 3-lead EKG. Measures were taken continuously from 5 minutes before the task to 10 minutes after the task. Rsults were then averaged across 4 periods: 5 minutes prior to the task, the 5-minute task period, and 5-, and 10-minutes post task

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Heart Rate Variability
Mean across minutes 1-5 post-task
6.18 log normal milliseconds
Standard Deviation 0.97
6.37 log normal milliseconds
Standard Deviation 0.85
Heart Rate Variability
Mean across 6-10 minutes post-task
6.30 log normal milliseconds
Standard Deviation 0.93
6.43 log normal milliseconds
Standard Deviation 0.91
Heart Rate Variability
Mean across 5 min pre-task
6.50 log normal milliseconds
Standard Deviation 1.05
6.58 log normal milliseconds
Standard Deviation 0.81
Heart Rate Variability
Mean across 5 min task period
5.94 log normal milliseconds
Standard Deviation 0.96
6.50 log normal milliseconds
Standard Deviation 0.92

SECONDARY outcome

Timeframe: 2 minutes before and 2, 60, and 120 minutes post-task periods

Momentary assessment of fatigue, measured as score on the fatigue subscale on the brief Profile of Mood States questionnaire. Scores range from 0 - 20, with higher scores reflecting more fatigue.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Fatigue
Pre-task
4.76 score on scale
Standard Deviation 4.02
5.47 score on scale
Standard Deviation 3.72
Fatigue
post-task
2.59 score on scale
Standard Deviation 2.75
5.36 score on scale
Standard Deviation 3.86
Fatigue
60 min post task onset
5.79 score on scale
Standard Deviation 4.15
6.48 score on scale
Standard Deviation 4.62
Fatigue
120 min post task onset
5.50 score on scale
Standard Deviation 4.50
5.41 score on scale
Standard Deviation 4.36

SECONDARY outcome

Timeframe: 2 minutes before and 2-, 60-, and 120-minutes post-task periods

Momentary assessment of anger, measured as score on the anger subscale on the brief Profile of Mood States questionnaire in response to the task periods. Scores range from 0 - 12, with higher scores reflecting more anger.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Anger
Pre-task
0.30 score on a scale
Standard Deviation 1.03
0.08 score on a scale
Standard Deviation 0.42
Anger
2 min post-task
0.70 score on a scale
Standard Deviation 1.57
0.20 score on a scale
Standard Deviation 1.05
Anger
60 min post task onset
0.49 score on a scale
Standard Deviation 1.39
0.16 score on a scale
Standard Deviation 0.72
Anger
120 min post task onset
0.45 score on a scale
Standard Deviation 1.51
0.14 score on a scale
Standard Deviation 0.59

SECONDARY outcome

Timeframe: 2 minutes before and 2-, 60- and 120-minutes post-task periods

Momentary assessment of anxious mood, measured as score on the anxiety subscale on the brief Profile of Mood States questionnaire in response to the task periods. Scores range from 0 - 16, with higher scores reflecting more anxious mood.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Anxious Mood
2 min pre-task
1.44 score on a scale
Standard Deviation 2.13
1.35 score on a scale
Standard Deviation 1.97
Anxious Mood
2 min post-task
3.21 score on a scale
Standard Deviation 2.78
0.93 score on a scale
Standard Deviation 1.97
Anxious Mood
60 min post task onset
1.56 score on a scale
Standard Deviation 2.21
1.24 score on a scale
Standard Deviation 2.30
Anxious Mood
120 min post task onset
1.29 score on a scale
Standard Deviation 2.18
1.02 score on a scale
Standard Deviation 2.46

SECONDARY outcome

Timeframe: 2 minutes before and 2-, 60- and 120-minutes post-task periods

Momentary assessment of depressed mood, measured as score on the depression subscale on the brief Profile of Mood States questionnaire in response to the task periods. Scores range from 0 - 12, with higher scores reflecting more depressed mood.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Depressed Mood
2 min pre-task
0.32 score on a scale
Standard Deviation 0.91
0.23 score on a scale
Standard Deviation 0.79
Depressed Mood
2 min post-task
0.46 score on a scale
Standard Deviation 1.20
0.27 score on a scale
Standard Deviation 0.94
Depressed Mood
60 min post task onset
0.64 score on a scale
Standard Deviation 1.34
0.29 score on a scale
Standard Deviation 0.94
Depressed Mood
120 min post task onset
0.41 score on a scale
Standard Deviation 1.12
0.25 score on a scale
Standard Deviation 0.88

SECONDARY outcome

Timeframe: 2 minutes before and 2-, 60-, and 120-minutes post-task periods

Momentary assessment of vigor, measured as score on the vigor subscale on the brief Profile of Mood States questionnaire in response to the task periods. Scores range from 0 - 12, with higher scores reflecting more vigor.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Vigor
2 min pre-task
1.84 score on a scale
Standard Deviation 1.97
1.65 score on a scale
Standard Deviation 1.87
Vigor
2 min post-task
3.19 score on a scale
Standard Deviation 2.28
1.54 score on a scale
Standard Deviation 1.81
Vigor
60 min post task onset
1.39 score on a scale
Standard Deviation 1.89
1.03 score on a scale
Standard Deviation 1.53
Vigor
120 min post task onset
1.91 score on a scale
Standard Deviation 2.30
1.66 score on a scale
Standard Deviation 2.09

SECONDARY outcome

Timeframe: 2 minutes before and 2-, 60- and 120-minutes post-task periods

Momentary assessment of wellbeing, measured as score on the wellbeing subscale on the brief Profile of Mood States questionnaire in response to the task periods. Scores range from 0 - 12, with higher scores reflecting more wellbeing.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Wellbeing
2 min pre-task
4.25 score on a scale
Standard Deviation 2.11
4.10 score on a scale
Standard Deviation 2.04
Wellbeing
2 min post-task
3.56 score on a scale
Standard Deviation 2.19
3.93 score on a scale
Standard Deviation 2.34
Wellbeing
60-min post-task
3.61 score on a scale
Standard Deviation 2.36
3.81 score on a scale
Standard Deviation 2.31
Wellbeing
120-min post-task
3.93 score on a scale
Standard Deviation 2.70
3.82 score on a scale
Standard Deviation 2.52

SECONDARY outcome

Timeframe: 2 minutes before and 2-, 60-, and 120-minutes post-task periods

Momentary assessment of calm mood, measured as score on the calm subscale on the brief Profile of Mood States questionnaire in response to the task periods. Scores range from 0 - 16, with higher scores reflecting more calm mood.

Outcome measures

Outcome measures
Measure
Socio-evaluative Speech Stress Session
n=63 Participants
Participants attended two laboratory sessions order of these sessions was counterbalanced. At one of the sessions, they completed a 5-minute socio-evaluative speech task defending themselves against an alleged transgression (e.g., running a stop sign). Outcomes in this condition include responses to this stressor.
Control Session
n=61 Participants
Participants attended two laboratory sessions. Order of sessions was counterbalanced. Presented outcome data are for the control condition only. Participants rested quietly for the 5-minute task period.
Calm Mood
2 min pre-task
9.09 score on a scale
Standard Deviation 2.85
9.38 score on a scale
Standard Deviation 2.90
Calm Mood
2 min post-task
5.87 score on a scale
Standard Deviation 2.84
8.83 score on a scale
Standard Deviation 3.39
Calm Mood
60- min post task onset
7.59 score on a scale
Standard Deviation 3.40
8.29 score on a scale
Standard Deviation 2.91
Calm Mood
120 min post task onset
7.68 score on a scale
Standard Deviation 3.18
7.63 score on a scale
Standard Deviation 3.50

Adverse Events

Socio-evaluative Speech Stress Session

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Session

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Anna Marsland

University of Pittsburgh

Phone: 14123705622

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place